Total planned funding: $50,099,792
Allocations
Countries/Regions
Central Asia Region | $50,099,792 |
Organizational Types
Own Agency | $19,306,087 |
University | $7,677,877 |
Unknown | $6,832,339 |
NGO | $6,806,993 |
Host Country Government Agency | $4,406,267 |
Private Contractor | $2,882,129 |
Multi-lateral Agency | $1,840,000 |
Other USG Agency | $181,100 |
Implementing Agency | $167,000 |
Program Areas
Management and Operations | $16,065,646 |
Prevention | $15,751,035 |
Governance and Systems | $10,653,808 |
Care | $3,354,589 |
Treatment | $2,598,385 |
Testing | $1,676,329 |
Budget Codes
HVMS: Management and Operations | $16,065,646 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $11,250,990 |
HLAB: Laboratory Infrastructure | $4,196,979 |
OHSS: Health Systems Strengthening | $3,495,510 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,473,483 |
HBHC: Care: Adult Care and Support | $3,274,813 |
HVSI: Strategic Information | $2,961,319 |
HTXS: Treatment: Adult Treatment | $2,572,365 |
HVCT: Testing: HIV Testing and Counseling | $1,676,329 |
HMBL: Biomedical Prevention: Blood Safety | $717,107 |
HMIN: Biomedical Prevention: Injection Safety | $309,455 |
HVTB: Care: TB/HIV | $79,776 |
HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
USG Aggregated Agencies:
$13,529,087
Countries/Regions
Central Asia Region
2010 | $3,180,975 |
2011 | $5,099,999 |
2012 | $1,121,824 |
2016 | $4,126,289 |
Columbia University:
$7,677,877
Countries/Regions
Central Asia Region
2011 | $927,743 |
2012 | $979,042 |
2013 | $2,374,000 |
2016 | $3,397,092 |
Not Available:
$6,832,339
Countries/Regions
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
2013 | $3,238,500 |